CTP-6: Phase III data

Pooled data from 475 patients with confirmed HER2-positive metastatic breast cancer in the intent-to-treat (ITT) populations of 2 double-blind, international Phase I/IIb and III trials showed that CTP-6 plus

Read the full 297 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE